Introduction
I grew up in mainland China, where I obtained a bachelor’s degree in preventive medicine at Shandong University (2015) and an MSc at Peking University (2018). I began my UK journey, first as a training fellow (2019) and later as a DPhil student at the University of Oxford (2023). Currently, I am a post-doctoral researcher and lead large Biobank studies within Professor Daniel Prieto-Alhambra’s group at NDORMS. In 2024, I joined The Queen’s College as an Extraordinary Junior Research Fellow in Clinical Sciences.
Research
My research focus is on population health. In my work, I collaborate extensively with interdisciplinary teams and generate trustworthy evidence for clinical and regulatory decision-making using big data and innovative methods. I also have strong interests in modern pharmacogenomics, which harnesses the power of human genome to optimize drug’ effects (efficacy/ safety) for patients. Through this, I contribute to the understanding, translation and implementation of personalized medication for real people in real life.
Publications
Xie J, Strauss VY, Martinez-Laguna D, et al. Association of Tramadol vs Codeine Prescription Dispensation With Mortality and Other Adverse Clinical Outcomes. JAMA. 2021;326(15)
Xie J, Prats-Uribe A, Feng Q, et al. Clinical and Genetic Risk Factors for Acute Incident Venous Thromboembolism in Ambulatory Patients With COVID-19. JAMA Intern Med. 2022;182(10)
Xie, J, Mothe, B., Alcalde Herraiz, M. et al. Relationship Between HLA Genetic Variations, COVID-19 Vaccine Antibody Response, And Risk Of Breakthrough Outcomes. Nat Communications, 2024
An up-to-date list of publications is available here.